• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登革病毒对I型干扰素反应的控制:操纵与调控的历史

Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.

作者信息

Castillo Ramirez Jorge Andrés, Urcuqui-Inchima Silvio

机构信息

Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA , Medellín, Colombia .

出版信息

J Interferon Cytokine Res. 2015 Jun;35(6):421-30. doi: 10.1089/jir.2014.0129. Epub 2015 Jan 28.

DOI:10.1089/jir.2014.0129
PMID:25629430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4490770/
Abstract

The arthropod-borne diseases caused by dengue virus (DENV) are a major and emerging problem of public health worldwide. Infection with DENV causes a series of clinical manifestations ranging from mild flu syndrome to severe diseases that include hemorrhage and shock. It has been demonstrated that the innate immune response plays a key role in DENV pathogenesis. However, in recent years, it was shown that DENV evades the innate immune response by blocking type I interferon (IFN-I). It has been demonstrated that DENV can inhibit both the production and the signaling of IFN-I. The viral proteins, NS2A and NS3, inhibit IFN-I production by degrading cellular signaling molecules. In addition, the viral proteins, NS2A, NS4A, NS4B, and NS5, can inhibit IFN-I signaling by blocking the phosphorylation of the STAT1 and STAT2 molecules. Finally, NS5 mediates the degradation of STAT2 using the proteasome machinery. In this study, we briefly review the most recent insights regarding the IFN-I response to DENV infection and its implication for pathogenesis.

摘要

由登革病毒(DENV)引起的虫媒疾病是全球公共卫生领域一个重大且不断出现的问题。感染DENV会引发一系列临床表现,从轻微流感综合征到包括出血和休克在内的严重疾病。已有研究表明,先天免疫反应在DENV发病机制中起关键作用。然而,近年来研究发现,DENV通过阻断I型干扰素(IFN-I)来逃避先天免疫反应。研究表明,DENV既能抑制IFN-I的产生,也能抑制其信号传导。病毒蛋白NS2A和NS3通过降解细胞信号分子来抑制IFN-I的产生。此外,病毒蛋白NS2A、NS4A、NS4B和NS5可通过阻断信号转导和转录激活因子1(STAT1)和信号转导和转录激活因子2(STAT2)分子的磷酸化来抑制IFN-I信号传导。最后,NS5利用蛋白酶体机制介导STAT2的降解。在本研究中,我们简要回顾了关于IFN-I对DENV感染的反应及其对发病机制影响的最新见解。

相似文献

1
Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.登革病毒对I型干扰素反应的控制:操纵与调控的历史
J Interferon Cytokine Res. 2015 Jun;35(6):421-30. doi: 10.1089/jir.2014.0129. Epub 2015 Jan 28.
2
Innate immunity evasion by Dengue virus.登革热病毒的先天免疫逃避。
Viruses. 2012 Mar;4(3):397-413. doi: 10.3390/v4030397. Epub 2012 Mar 15.
3
Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.登革病毒通过靶向衔接蛋白MAVS来颠覆宿主天然免疫。
J Virol. 2016 Jul 27;90(16):7219-7230. doi: 10.1128/JVI.00221-16. Print 2016 Aug 15.
4
Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.登革病毒非结构蛋白通过阻断TBK1/IRF3磷酸化抑制RIG-I/MAVS信号传导:登革病毒1型NS4A是一种独特的干扰素调节毒力决定因素。
mBio. 2015 May 12;6(3):e00553-15. doi: 10.1128/mBio.00553-15.
5
Structural modeling and analysis of dengue-mediated inhibition of interferon signaling pathway.登革热介导的干扰素信号通路抑制的结构建模与分析
Genet Mol Res. 2015 Apr 28;14(2):4215-37. doi: 10.4238/2015.April.28.4.
6
STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.STAT2 通过 I 型干扰素受体在没有 STAT1 的情况下介导登革热病毒的先天免疫。
PLoS Pathog. 2011 Feb;7(2):e1001297. doi: 10.1371/journal.ppat.1001297. Epub 2011 Feb 17.
7
Innate immunity to dengue virus infection and subversion of antiviral responses.先天免疫对登革热病毒感染和抗病毒反应的颠覆。
J Mol Biol. 2014 Mar 20;426(6):1148-60. doi: 10.1016/j.jmb.2013.11.023. Epub 2013 Dec 3.
8
NS5 of dengue virus mediates STAT2 binding and degradation.登革病毒的NS5介导信号转导和转录激活因子2(STAT2)的结合与降解。
J Virol. 2009 Jun;83(11):5408-18. doi: 10.1128/JVI.02188-08. Epub 2009 Mar 11.
9
Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.登革热病毒结构蛋白和非结构蛋白的高保守表位:通用疫苗靶点的候选者。
Gene. 2019 May 5;695:18-25. doi: 10.1016/j.gene.2019.02.001. Epub 2019 Feb 8.
10
Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.利用从黄热病疫苗成功中获得的知识指导登革热疫苗的研发。
Cell Mol Immunol. 2016 Jan;13(1):36-46. doi: 10.1038/cmi.2015.76. Epub 2015 Oct 5.

引用本文的文献

1
Dengue virus: structure, genome, evolution and challenges to control and prevent transmission.登革病毒:结构、基因组、进化以及控制和预防传播面临的挑战
Antonie Van Leeuwenhoek. 2025 Aug 26;118(9):139. doi: 10.1007/s10482-025-02153-1.
2
Vitamin D enhances antiviral responses in dengue virus-infected macrophages by modulating early-response gene expression.维生素D通过调节早期反应基因的表达来增强登革病毒感染的巨噬细胞中的抗病毒反应。
PLoS One. 2025 Aug 21;20(8):e0330751. doi: 10.1371/journal.pone.0330751. eCollection 2025.
3
Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis.在登革病毒1型人类感染模型中观察到的干扰素介导信号诱导的时间差异量化:纵向蛋白质组分析的见解
EBioMedicine. 2025 May;115:105728. doi: 10.1016/j.ebiom.2025.105728. Epub 2025 Apr 26.
4
Pathogenesis and clinical management of arboviral diseases.虫媒病毒病的发病机制与临床管理
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
5
Recent updates of interferon-derived myxovirus resistance protein A as a biomarker for acute viral infection.干扰素衍生的黏液病毒抗性蛋白A作为急性病毒感染生物标志物的最新进展。
Eur J Med Res. 2024 Dec 23;29(1):612. doi: 10.1186/s40001-024-02221-8.
6
Exploring the Contrasts and Similarities of Dengue and SARS-CoV-2 Infections During the COVID-19 Era.探讨 COVID-19 时代登革热和 SARS-CoV-2 感染的差异与相似之处。
Int J Mol Sci. 2024 Oct 29;25(21):11624. doi: 10.3390/ijms252111624.
7
Immunomodulation in dengue: towards deciphering dengue severity markers.登革热的免疫调节:探索登革热严重程度标志物。
Cell Commun Signal. 2024 Sep 26;22(1):451. doi: 10.1186/s12964-024-01779-4.
8
Immunologic Crosstalk and Host-Specific Immune Signature Associated with Dengue.与登革热相关的免疫串扰和宿主特异性免疫特征
ACS Omega. 2024 Aug 20;9(36):37418-37429. doi: 10.1021/acsomega.4c02506. eCollection 2024 Sep 10.
9
Trends and insights in dengue virus research globally: a bibliometric analysis (1995-2023).全球登革热病毒研究的趋势和洞察:文献计量分析(1995-2023)。
J Transl Med. 2024 Sep 3;22(1):818. doi: 10.1186/s12967-024-05561-5.
10
The Dynamic Relationship between Dengue Virus and the Human Cutaneous Innate Immune Response.登革病毒与人类皮肤固有免疫反应的动态关系。
Viruses. 2024 May 4;16(5):727. doi: 10.3390/v16050727.

本文引用的文献

1
G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA.G3BP1、G3BP2和CAPRIN1是干扰素刺激的mRNA翻译所必需的,并且是登革热病毒非编码RNA的作用靶点。
PLoS Pathog. 2014 Jul 3;10(7):e1004242. doi: 10.1371/journal.ppat.1004242. eCollection 2014 Jul.
2
Association of dengue virus infection susceptibility with polymorphisms of 2'-5'-oligoadenylate synthetase genes: a case-control study.登革病毒感染易感性与 2'-5'-寡聚腺苷酸合成酶基因多态性的关联:一项病例对照研究。
Braz J Infect Dis. 2014 Sep-Oct;18(5):548-50. doi: 10.1016/j.bjid.2014.03.004. Epub 2014 May 9.
3
Activation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus.PKR/eIF2α 信号级联的激活抑制新城疫病毒的复制。
Virol J. 2014 Mar 31;11:62. doi: 10.1186/1743-422X-11-62.
4
Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.通过 RIG-I 介导的先天抗病毒反应的 I 型干扰素非依赖性刺激抑制登革热和基孔肯雅病毒感染。
J Virol. 2014 Apr;88(8):4180-94. doi: 10.1128/JVI.03114-13. Epub 2014 Jan 29.
5
Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.登革病毒通过NS2B/3蛋白酶与IκB激酶ε相互作用来破坏干扰素诱导途径。
Clin Vaccine Immunol. 2014 Jan;21(1):29-38. doi: 10.1128/CVI.00500-13. Epub 2013 Oct 30.
6
The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus.IRF-3 和 IRF-7 在抗病毒固有免疫防御登革热病毒中的作用。
J Immunol. 2013 Oct 15;191(8):4194-201. doi: 10.4049/jimmunol.1300799. Epub 2013 Sep 16.
7
Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.理解丙型肝炎病毒(HCV)诱导干扰素耐药的分子机制。
Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5.
8
miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6.miR-146a 通过靶向 TRAF6 抑制干扰素诱导来促进登革热病毒的复制。
J Infect. 2013 Oct;67(4):329-41. doi: 10.1016/j.jinf.2013.05.003. Epub 2013 May 16.
9
The global distribution and burden of dengue.登革热的全球分布和负担。
Nature. 2013 Apr 25;496(7446):504-7. doi: 10.1038/nature12060. Epub 2013 Apr 7.
10
Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.登革热病毒劫持 UBR4 降解 STAT2 并拮抗 I 型干扰素信号通路。
PLoS Pathog. 2013 Mar;9(3):e1003265. doi: 10.1371/journal.ppat.1003265. Epub 2013 Mar 28.